Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 5, 1990

Conditions
Kidney CancerUrologic Malignant DisordersRenal Cell CarcinomaFamilial Renal Cancer (FRC)Clear Cell Renal Cancer
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH